Severe multisystem inflammatory syndrome in a vaccinated adult with COVID-19

The ability of SARS-CoV-2 to trigger hyperinflammatory response in children and adults is increasingly recognised. However, the detailed features that distinguish severe COVID-19-associated hyperinflammation from multisystem inflammatory syndrome in adults (MIS-A) is not yet known. We describe a you...

Descripción completa

Detalles Bibliográficos
Autores principales: Selvaraj, Vijairam, Finn, Arkadiy, Santos, Michael, Dapaah-Afriyie, Kwame
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Case Reports: Rare disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045045/
https://www.ncbi.nlm.nih.gov/pubmed/35473700
http://dx.doi.org/10.1136/bcr-2022-249425
_version_ 1784695226042941440
author Selvaraj, Vijairam
Finn, Arkadiy
Santos, Michael
Dapaah-Afriyie, Kwame
author_facet Selvaraj, Vijairam
Finn, Arkadiy
Santos, Michael
Dapaah-Afriyie, Kwame
author_sort Selvaraj, Vijairam
collection PubMed
description The ability of SARS-CoV-2 to trigger hyperinflammatory response in children and adults is increasingly recognised. However, the detailed features that distinguish severe COVID-19-associated hyperinflammation from multisystem inflammatory syndrome in adults (MIS-A) is not yet known. We describe a young, vaccinated patient with no prior SARS-CoV-2 exposure who developed COVID-19 and MIS-A. We also provide a review of the current literature on MIS-A and COVID-19-associated hyperinflammation.
format Online
Article
Text
id pubmed-9045045
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-90450452022-05-11 Severe multisystem inflammatory syndrome in a vaccinated adult with COVID-19 Selvaraj, Vijairam Finn, Arkadiy Santos, Michael Dapaah-Afriyie, Kwame BMJ Case Rep Case Reports: Rare disease The ability of SARS-CoV-2 to trigger hyperinflammatory response in children and adults is increasingly recognised. However, the detailed features that distinguish severe COVID-19-associated hyperinflammation from multisystem inflammatory syndrome in adults (MIS-A) is not yet known. We describe a young, vaccinated patient with no prior SARS-CoV-2 exposure who developed COVID-19 and MIS-A. We also provide a review of the current literature on MIS-A and COVID-19-associated hyperinflammation. BMJ Publishing Group 2022-04-25 /pmc/articles/PMC9045045/ /pubmed/35473700 http://dx.doi.org/10.1136/bcr-2022-249425 Text en © BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.
spellingShingle Case Reports: Rare disease
Selvaraj, Vijairam
Finn, Arkadiy
Santos, Michael
Dapaah-Afriyie, Kwame
Severe multisystem inflammatory syndrome in a vaccinated adult with COVID-19
title Severe multisystem inflammatory syndrome in a vaccinated adult with COVID-19
title_full Severe multisystem inflammatory syndrome in a vaccinated adult with COVID-19
title_fullStr Severe multisystem inflammatory syndrome in a vaccinated adult with COVID-19
title_full_unstemmed Severe multisystem inflammatory syndrome in a vaccinated adult with COVID-19
title_short Severe multisystem inflammatory syndrome in a vaccinated adult with COVID-19
title_sort severe multisystem inflammatory syndrome in a vaccinated adult with covid-19
topic Case Reports: Rare disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045045/
https://www.ncbi.nlm.nih.gov/pubmed/35473700
http://dx.doi.org/10.1136/bcr-2022-249425
work_keys_str_mv AT selvarajvijairam severemultisysteminflammatorysyndromeinavaccinatedadultwithcovid19
AT finnarkadiy severemultisysteminflammatorysyndromeinavaccinatedadultwithcovid19
AT santosmichael severemultisysteminflammatorysyndromeinavaccinatedadultwithcovid19
AT dapaahafriyiekwame severemultisysteminflammatorysyndromeinavaccinatedadultwithcovid19

Ejemplares similares